**Core Concept**
The **renin-angiotensin-aldosterone system (RAAS)** plays a crucial role in regulating blood pressure and electrolyte balance. **Plasma renin activity** is an indicator of the RAAS's status. Certain drugs can influence this system, either by enhancing or suppressing its activity.

**Why the Correct Answer is Right**
The correct answer is likely a drug that suppresses the RAAS, such as a **beta-blocker** or a **direct renin inhibitor**. These drugs decrease plasma renin activity by either reducing the sympathetic stimulation of renin release or directly inhibiting renin's action. This leads to a decrease in the formation of **angiotensin II** and **aldosterone**, resulting in vasodilation and decreased blood pressure.

**Why Each Wrong Option is Incorrect**
**Option A:** May actually increase plasma renin activity as a compensatory response.
**Option B:** Might have variable effects on the RAAS, depending on the specific context.
**Option D:** Could potentially increase renin release due to reflex mechanisms.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **beta-blockers** are known to decrease plasma renin activity, which is why they are often used in the treatment of **hypertension** and **heart failure**.

**Correct Answer:** D. Propranolol.